Heron Therapeutics: Fourth Quarter Earnings Overview

Heron Therapeutics Reports Fourth Quarter Financial Results

Heron Therapeutics Inc., based in Cary, North Carolina, announced on Thursday that it recorded a net loss of $3 million for the fourth quarter.

This translates to a loss of 2 cents per share for the period.

The company, which specializes in pharmaceuticals, generated $40.6 million in revenue during the quarter.

For the entire fiscal year, Heron Therapeutics reported a total loss of $20.2 million, or 12 cents per share, with annual revenue reaching $154.9 million.

Looking ahead, the company anticipates its revenue for the upcoming year will fall between $173 million and $183 million.